The spring is knocking on our doors (in the northern hemisphere) which makes us increasingly optimistic.
Maja Čemažar is briefly presenting the results of a phase I clinical study – first in Europe, where phIL12 plasmid was introduced intratumorally by electroporation in patients with basal cell carcinoma.
The study is the culmination of the Smartgene (https://www.smartgene.si/) project.
Yours,
Damijan Miklavčič
Newsletter Editor